Updated on 2024/10/31

写真a

 
FURUTA Kazuyuki
 
Organization
Faculty of Medicine, Dentistry and Pharmaceutical Sciences Associate Professor
Position
Associate Professor
External link

Degree

  • 博士(薬学) ( 京都大学 )

Research Interests

  • Dendritic cell

  • Antigen presentation

  • マスト細胞

  • 免疫

Research Areas

  • Life Science / Pharmaceutical hygiene and biochemistry

Education

  • 京都大学大学院   薬学研究科   生命薬科学 博士後期課程修了

    2006.3

      More details

  • Kyoto University   薬学部   総合薬学科 卒業

    2001.3

      More details

Research History

  • Okayama University   Graduate School of Medicine , Dentistry and Pharmaceutical Sciences   Associate Professor

    2014.4

      More details

  • Okayama University   Graduate School of Medicine , Dentistry and Pharmaceutical Sciences   Assistant Professor

    2012.8 - 2014.3

      More details

  • National Institutes of Hearth   National Cancer Institute

    2008.4 - 2012.7

      More details

  • Mukogawa Women's University   School of Pharmacy and Pharmaceutical Sciences

    2006.4 - 2008.3

      More details

Professional Memberships

Committee Memberships

  • 日本生化学会   「生化学」誌企画協力委員  

    2014 - 2020   

      More details

    Committee type:Academic society

    researchmap

  • 日本薬学会   ファルマシアトピックス専門小委員  

    2014 - 2016   

      More details

    Committee type:Academic society

    researchmap

 

Papers

  • Suppression of Mast Cell Activation by GPR35: GPR35 Is a Primary Target of Disodium Cromoglycate. Reviewed International journal

    Masumi Oka, Sohta Akaki, Osamu Ohno, Maho Terasaki, Yuho Hamaoka-Tamura, Michiko Saito, Shinichi Kato, Asuka Inoue, Junken Aoki, Kenji Matsuno, Kazuyuki Furuta, Satoshi Tanaka

    The Journal of pharmacology and experimental therapeutics   389 ( 1 )   76 - 86   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mast cell stabilizers, including disodium cromoglycate (DSCG), were found to have potential as the agonists of an orphan G protein-coupled receptor, GPR35, although it remains to be determined whether GPR35 is expressed in mast cells and involved in suppression of mast cell degranulation. Our purpose in this study is to verify the expression of GPR35 in mast cells and to clarify how GPR35 modulates the degranulation. We explored the roles of GPR35 using an expression system, a mast cell line constitutively expressing rat GPR35, peritoneal mast cells, and bone marrow-derived cultured mast cells. Immediate allergic responses were assessed using the IgE-mediated passive cutaneous anaphylaxis (PCA) model. Various known GPR35 agonists, including DSCG and newly designed compounds, suppressed IgE-mediated degranulation. GPR35 was expressed in mature mast cells but not in immature bone marrow-derived cultured mast cells and the rat mast cell line. Degranulation induced by antigens was significantly downmodulated in the mast cell line stably expressing GPR35. A GPR35 agonist, zaprinast, induced a transient activation of RhoA and a transient decrease in the amount of filamentous actin. GPR35 agonists suppressed the PCA responses in the wild-type mice but not in the GPR35-/- mice. These findings suggest that GPR35 should prevent mast cells from undergoing degranulation induced by IgE-mediated antigen stimulation and be the primary target of mast cell stabilizers. SIGNIFICANCE STATEMENT: The agonists of an orphan G protein-coupled receptor, GPR35, including disodium cromoglycate, were found to suppress degranulation of rat and mouse mature mast cells, and their antiallergic effects were abrogated in the GPR35-/- mice, indicating that the primary target of mast cell stabilizers should be GPR35.

    DOI: 10.1124/jpet.123.002024

    PubMed

    researchmap

  • Knockout of adenylosuccinate synthase purA increases susceptibility to colistin in Escherichia coli Reviewed

    Tomonori Kano, Kazuya Ishikawa, Kazuyuki Furuta, Chikara Kaito

    FEMS Microbiology Letters   2024.2

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Colistin is a cationic cyclic antimicrobial peptide used as a last resort against multidrug-resistant gram-negative bacteria. To understand the factors involved in colistin susceptibility, we screened colistin-sensitive mutants from an E. coli gene-knockout library (Keio collection). The knockout of purA, whose product catalyzes the synthesis of adenylosuccinate from IMP in the de novo purine synthesis pathway, resulted in increased sensitivity to colistin. Adenylosuccinate is subsequently converted to AMP, which is phosphorylated to produce ADP, a substrate for ATP synthesis. The amount of ATP was lower in the purA-knockout mutant than that in the wild-type strain. ATP synthesis is coupled with proton transfer, and it contributes to the membrane potential. Using the membrane potential probe, 3,3′-diethyloxacarbocyanine iodide [DiOC2(3)], we found that the membrane was hyperpolarized in the purA-knockout mutant compared to that in the wild-type strain. Treatment with the proton uncoupler, carbonyl cyanide m-chlorophenyl hydrazone (CCCP), abolished the hyperpolarization and colistin sensitivity in the mutant. The purA-knockout mutant exhibited increased sensitivity to aminoglycosides, kanamycin, and gentamicin; their uptake requires a membrane potential. Therefore, the knockout of purA, an adenylosuccinate synthase, decreases ATP synthesis concurrently with membrane hyperpolarization, resulting in increased sensitivity to colistin.

    DOI: 10.1093/femsle/fnae007

    researchmap

  • Overexpression of the flagellar motor protein MotB sensitizes Bacillus subtilis to aminoglycosides in a motility-independent manner. International journal

    Mio Uneme, Kazuya Ishikawa, Kazuyuki Furuta, Atsuko Yamashita, Chikara Kaito

    PloS one   19 ( 4 )   e0300634   2024

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The flagellar motor proteins, MotA and MotB, form a complex that rotates the flagella by utilizing the proton motive force (PMF) at the bacterial cell membrane. Although PMF affects the susceptibility to aminoglycosides, the effect of flagellar motor proteins on the susceptibility to aminoglycosides has not been investigated. Here, we found that MotB overexpression increased susceptibility to aminoglycosides, such as kanamycin and gentamicin, in Bacillus subtilis without affecting swimming motility. MotB overexpression did not affect susceptibility to ribosome-targeting antibiotics other than aminoglycosides, cell wall-targeting antibiotics, DNA synthesis-inhibiting antibiotics, or antibiotics inhibiting RNA synthesis. Meanwhile, MotB overexpression increased the susceptibility to aminoglycosides even in the motA-deletion mutant, which lacks swimming motility. Overexpression of the MotB mutant protein carrying an amino acid substitution at the proton-binding site (D24A) resulted in the loss of the enhanced aminoglycoside-sensitive phenotype. These results suggested that MotB overexpression sensitizes B. subtilis to aminoglycosides in a motility-independent manner. Notably, the aminoglycoside-sensitive phenotype induced by MotB requires the proton-binding site but not the MotA/MotB complex formation.

    DOI: 10.1371/journal.pone.0300634

    PubMed

    researchmap

  • Overexpression of diglucosyldiacylglycerol synthase leads to daptomycin resistance in Bacillus subtilis Reviewed

    Ryogo Yamamoto, Kazuya Ishikawa, Yusuke Miyoshi, Kazuyuki Furuta, Shin-Ichi Miyoshi, Chikara Kaito

    J Bacteriol.   2024

  • Short‐chain fatty acids stimulate dendrite elongation in dendritic cells by inhibiting histone deacetylase Reviewed

    Takuho Inamoto, Kazuyuki Furuta, Cheng Han, Mio Uneme, Tomonori Kano, Kazuya Ishikawa, Chikara Kaito

    The FEBS Journal   2023.8

     More details

    Authorship:Corresponding author   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Dendritic cells activate immune responses by presenting pathogen‐derived molecules. The dendrites of dendritic cells contribute to the incorporation of foreign antigens or presenting antigens to T cells. Short‐chain fatty acids (SCFAs), such as acetic, propionic, butyric, and valeric acids, have many effects on immune responses by activating specific receptors or inhibiting a histone deacetylase (HDAC), but their effect on dendrite formation in dendritic cells is unknown. In this study, we aimed to investigate the effect of SCFAs on dendrite elongation using a dendritic cell line (DC2.4 cells) and mouse bone marrow‐derived dendritic cells (BMDCs). We found that SCFAs induced dendrite elongation. The elongation was reduced by inhibitors of Src family kinase (SFK), PI3K, Rho family GTPases (Cdc42, Rac1), or actin polymerization, indicating that SCFAs promote dendrite elongation by activating actin polymerization via the SFK/PI3K/Rho family GTPase signaling pathway. We showed that agonists for SCFA receptors GPR43 and GPR109a did not promote dendrite elongation. In contrast, HDAC inhibitors, including trichostatin A (TSA), promoted dendrite elongation in DC2.4 cells, and the promoting activity of TSA was decreased by inhibiting the SFK/PI3K/Rho family GTPase signaling pathway or actin polymerization. Furthermore, DC2.4 cells treated with valeric acid showed enhanced uptake of soluble proteins, insoluble beads, and Staphylococcus aureus. We also found that treatment with valeric acid enhanced MHC‐II‐mediated antigen presentation in BMDCs. These results suggest that SCFAs promote dendrite elongation by inhibiting HDAC, stimulating the SFK/PI3K/Rho family pathway, and activating actin polymerization, resulting in increased antigen uptake and presentation in dendritic cells.

    DOI: 10.1111/febs.16945

    researchmap

  • Nicotine- and tar-removed cigarette smoke extract modulates the antigen presentation function of mouse bone marrow-derived dendritic cells. Reviewed International journal

    Kazuyuki Furuta, Takehiro Yoshioka, Kana Nishikaze, Noriko Yoshikawa, Kazuki Nakamura, Chikara Kaito

    Microbiology and immunology   67 ( 5 )   264 - 273   2023.5

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Dendritic cells (DCs) take up antigens derived from pathogens such as bacteria and viruses, and from tumor cells and induce the activation of antigen-specific T cells through major histocompatibility complex (MHC)-mediated antigen presentation. Mainstream cigarette smoke extract (CSE) has various effects, and the effects of its major components, nicotine and tar, have been extensively analyzed. Recently, the physiological effects of nicotine- and tar-removed CSE (cCSE) have also been reported. However, the effects of cCSE on DC-mediated immune responses remain unknown. In this study, we found that cCSE enhanced lipopolysaccharide (LPS)-stimulated induction of the expression of MHC-I and MHC-II on the cell surface of mouse bone marrow-derived DCs (BMDCs). In contrast, cCSE suppressed the induction of CD86 induced by stimulation with curdlan and interferon-gamma (IFN-γ). In addition, cCSE suppressed the production of IL-12, IL-23, and IL-10 by LPS and curdlan stimulation. In the presence of cCSE, LPS-stimulated BMDCs showed enhanced activation of CD4 and CD8 T cells and increased IL-2 production from T cells by antigen presentation in a mixed-leukocyte reaction assay. In contrast, cCSE did not affect the activation of T cells by curdlan- or IFN-γ-stimulated BMDCs, and curdlan-stimulated BMDCs suppressed IL-17 production from T cells and enhanced IFN-γ production. These results suggest that cCSE has different effects on the activation signals induced by LPS, curdlan, and IFN-γ in BMDCs and modulates the antigen presentation function of BMDCs. This article is protected by copyright. All rights reserved.

    DOI: 10.1111/1348-0421.13061

    PubMed

    researchmap

  • ATP and its metabolite adenosine cooperatively upregulate the antigen-presenting molecules on dendritic cells leading to IFN-γ production by T cells Reviewed

    Kazuyuki Furuta, Hiroka Onishi, Yuki Ikada, Kento Masaki, Satoshi Tanaka, Chikara Kaito

    Journal of Biological Chemistry   299 ( 4 )   104587 - 104587   2023.4

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.jbc.2023.104587

    PubMed

    researchmap

  • Knockout of ribosomal protein RpmJ leads to zinc resistance in Escherichia coli Reviewed

    Riko Shirakawa, Kazuya Ishikawa, Kazuyuki Furuta, Chikara Kaito

    PLOS ONE   18 ( 3 )   e0277162 - e0277162   2023.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Public Library of Science (PLoS)  

    Zinc is an essential metal for cells, but excess amounts are toxic. Other than by regulating the intracellular zinc concentration by zinc uptake or efflux, the mechanisms underlying bacterial resistance to excess zinc are unknown. In the present study, we searched for zinc-resistant mutant strains from the Keio collection, a gene knockout library of Escherichia coli, a model gram-negative bacteria. We found that knockout mutant of RpmJ (L36), a 50S ribosomal protein, exhibited zinc resistance. The rpmJ mutant was sensitive to protein synthesis inhibitors and had altered translation fidelity, indicating ribosomal dysfunction. In the rpmJ mutant, the intracellular zinc concentration was decreased under excess zinc conditions. Knockout of ZntA, a zinc efflux pump, abolished the zinc-resistant phenotype of the rpmJ mutant. RNA sequence analysis revealed that the rpmJ mutant exhibited altered gene expression of diverse functional categories, including translation, energy metabolism, and stress response. These findings suggest that knocking out RpmJ alters gene expression patterns and causes zinc resistance by lowering the intracellular zinc concentration. Knockouts of other ribosomal proteins, including RplA, RpmE, RpmI, and RpsT, also led to a zinc-resistant phenotype, suggesting that deletion of ribosomal proteins is closely related to zinc resistance.

    DOI: 10.1371/journal.pone.0277162

    researchmap

  • Staphylococcus aureus MazG hydrolyzes oxidized guanine nucleotides and contributes to oxidative stress resistance. Reviewed International journal

    Fuki Nigo, Ryosuke Nakagawa, Yuuki Hirai, Lina Imai, Yutaka Suzuki, Kazuyuki Furuta, Chikara Kaito

    Biochimie   209   52 - 60   2023.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We previously reported that knockout of the mazG (SA1292) gene decreases Staphylococcus aureus killing activity against silkworms. S. aureus MazG (SaMazG) has a nucleotide pyrophosphatase domain conserved among MazG family proteins, but its biochemical characteristics are unknown. In the present study, we purified recombinant N-terminal His-tagged SaMazG protein and examined its biochemical activity. SaMazG hydrolyzed GTP, UTP, dGTP, and TTP into nucleoside monophosphates. Hydrolytic activity of SaMazG against ATP, CTP, dATP, and dCTP was low or not detected. SaMazG exhibited high hydrolytic activity against 8-oxo-GTP and 8-oxo-dGTP, oxidized guanine nucleotides, with a Vmax/Km ratio more than 15-fold that of GTP. Furthermore, the S. aureus mazG knockout mutant was sensitive to hydrogen peroxide compared with the parent strain. These results suggest that SaMazG is a nucleotide pyrophosphatase hydrolyzing oxidized guanine nucleotides that contributes to the oxidative stress resistance of S. aureus.

    DOI: 10.1016/j.biochi.2023.02.001

    PubMed

    researchmap

  • Knockout of ykcB , a Putative Glycosyltransferase, Leads to Reduced Susceptibility to Vancomycin in Bacillus subtilis Reviewed

    Kazuya Ishikawa, Riko Shirakawa, Daiki Takano, Tomoki Kosaki, Kazuyuki Furuta, Chikara Kaito

    Journal of Bacteriology   2022.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Society for Microbiology  

    Although vancomycin is effective against Gram-positive bacteria, vancomycin-resistant bacteria are a major public health concern. While the vancomycin-resistance mechanisms of clinically important bacteria such as Staphylococcus aureus , Enterococcus faecium , and Streptococcus pneumoniae are well studied, they remain unclear in other Gram-positive bacteria.

    DOI: 10.1128/jb.00387-22

    researchmap

  • Knockout of mlaA increases Escherichia coli virulence in a silkworm infection model Reviewed

    Haruka Nasu, Riko Shirakawa, Kazuyuki Furuta, Chikara Kaito

    PLOS ONE   17 ( 7 )   e0270166 - e0270166   2022.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Public Library of Science (PLoS)  

    The mlaA gene encodes a lipoprotein to maintain an outer membrane lipid asymmetry in gram-negative bacteria. Although the role of mlaA in bacterial virulence has been studied in several bacterial species, there are no reports of its role in E. coli virulence. In this study, we found that knockout of mlaA in E. coli increased its virulence against silkworms. The mlaA-knockout mutant was sensitive to several antibiotics and detergents, but resistant to vancomycin and chlorhexidine. The mlaA-knockout mutant grew faster than the parent strain in the presence of silkworm hemolymph. The mlaA-knockout mutant also produced a larger amount of outer membrane vesicles than the parent strain. These findings suggest that mlaA knockout causes E. coli resistance to specific antimicrobial substances and increases outer membrane vesicle production, thereby enhancing E. coli virulence properties in the silkworm infection model.

    DOI: 10.1371/journal.pone.0270166

    researchmap

  • Roles of IgE and Histamine in Mast Cell Maturation. Reviewed International journal

    Satoshi Tanaka, Kazuyuki Furuta

    Cells   10 ( 8 )   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mast cells are activated upon immunoglobulin E (IgE)-mediated antigen stimulation, and release a wide variety of mediators, including histamine to trigger inflammatory responses. The surface expression levels of Fcε receptor I (FcεRI), a high affinity receptor of IgE, were found to be positively regulated by IgE. IgE could protect murine cultured mast cells from apoptotic cell death induced by the deprivation of interleukin-3 and a certain kind of IgE could activate immature mast cells in the absence of antigens, leading to the release of pro-inflammatory cytokines and a transient increase in histamine synthesis. Histamine synthesis in mast cells was found to be required for the maturation of murine connective tissue-type mast cells, raising the possibility that IgE indirectly modulates local mast cell maturation. Although it remains controversial to what extent this concept of "monomeric IgE effects" could have relevance in the modulation of human mast cell functions, the therapeutic effects of anti-IgE antibodies might be accounted for in terms of the decreased serum IgE concentrations. Because drastic increases in serum IgE concentrations are often observed in patients with atopic dermatitis and chronic urticaria, a close investigation of the roles of IgE in mast cell maturation should contribute to development of novel therapeutic approaches for these inflammatory diseases.

    DOI: 10.3390/cells10082170

    PubMed

    researchmap

  • The Absence of Osmoregulated Periplasmic Glucan Confers Antimicrobial Resistance and Increases Virulence in Escherichia coli. Reviewed International journal

    Kanade Murakami, Haruka Nasu, Takumi Fujiwara, Nao Takatsu, Naoki Yoshida, Kazuyuki Furuta, Chikara Kaito

    Journal of bacteriology   203 ( 12 )   e0051520   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Clarifying the molecular mechanisms by which bacteria acquire virulence traits is important for understanding the bacterial virulence system. In the present study, we utilized a bacterial evolution method in a silkworm infection model and revealed that deletion of the opgGH operon, encoding synthases for osmoregulated periplasmic glucan (OPG), increased the virulence of a nonpathogenic laboratory strain of Escherichia coli against silkworms. The opgGH knockout mutant exhibited resistance to host antimicrobial peptides and antibiotics. Compared with the parent strain, the opgGH knockout mutant produced greater amounts of colanic acid, which is involved in E. coli resistance to antibiotics. RNA sequence analysis revealed that the opgGH knockout altered the expression of various genes, including the evgS/evgA two-component system that functions in antibiotic resistance. In both a colanic acid-negative background and an evgS-null background, the opgGH knockout increased E. coli resistance to antibiotics and increased the silkworm-killing activity of E. coli. In the null background of the envZ/ompR two-component system, which genetically interacts with opgGH, the opgGH knockout increased antibiotic resistance and virulence in silkworms. These findings suggest that the absence of OPG confers antimicrobial resistance and virulence in E. coli in a colanic acid-, evgS/evgA-, and envZ/ompR-independent manner. IMPORTANCE The gene mutation types that increase the bacterial virulence of Escherichia coli remain unclear, in part due to the limited number of methods available for isolating bacterial mutants with increased virulence. We utilized a bacterial evolution method in the silkworm infection model, in which silkworms were infected with mutagenized bacteria and highly virulent bacterial mutants were isolated from dead silkworms. We revealed that knockout of OPG synthases increased E. coli virulence against silkworms. The OPG knockout mutants were resistant to host antimicrobial peptides as well as antibiotics. Our findings not only suggest a novel mechanism for virulence acquisition in E. coli but also support the usefulness of the bacterial experimental evolution method in the silkworm infection model.

    DOI: 10.1128/JB.00515-20

    PubMed

    researchmap

  • Proteolytic cleavage of HLA class II by human neutrophil elastase in pneumococcal pneumonia Reviewed

    Domon H, Maekawa T, Isono T, Furuta K, Kaito C, Terao Y

    Scientific Reports   11 ( 1 )   2021

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    <title>Abstract</title>Bacterial and viral respiratory infections can initiate acute lung injury and acute respiratory distress syndrome. Neutrophils and their granule enzymes, including neutrophil elastase, are key mediators of the pathophysiology of acute respiratory failure. Although intracellular neutrophil elastase functions as a host defensive factor against pathogens, its leakage into airway spaces induces degradation of host connective tissue components. This leakage disrupts host innate immune responses via proteolytic cleavage of Toll-like receptors and cytokines. Here, we investigated whether neutrophils possess proteases that cleave adaptive immune molecules. We found that expression of the human leukocyte antigen (HLA) class II molecule HLA-DP β1 was decreased in THP-1-derived macrophages treated with supernatants from dead neutrophils. This decreased HLA-DP β1 expression was counteracted by treatment with neutrophil elastase inhibitor, suggesting proteolytic cleavage of HLA-DP β1 by neutrophil elastase. SDS-PAGE showed that neutrophil elastase cleaved recombinant HLA-DP α1, -DP β1, -DQ α1, -DQ β1, -DR α, and -DR β1. Neutrophil elastase also cleaved HLA-DP β1 on extracellular vesicles isolated from macrophages without triggering morphological changes. Thus, leakage of neutrophil elastase may disrupt innate immune responses, antigen presentation, and T cell activation. Additionally, inhibition of neutrophil elastase is a potential therapeutic option for treating bacterial and viral pneumonia.

    DOI: 10.1038/s41598-021-82212-5

    researchmap

    Other Link: http://www.nature.com/articles/s41598-021-82212-5

  • Animal infection models using non-mammals. Reviewed International journal

    Chikara Kaito, Kanade Murakami, Lina Imai, Kazuyuki Furuta

    Microbiology and immunology   2020.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The use of non-human animal models for infection experiments is important for investigating the infectious processes of human pathogenic bacteria at the molecular level. Mammals, such as mice and rabbits, are also utilized as animal infection models, but large numbers of animals are needed for these experiments, which is costly, and fraught with ethical issues. Various non-mammalian animal infection models have been used to investigate the molecular mechanisms of various human pathogenic bacteria, including Staphylococcus aureus, Streptococcus pyogenes, and Pseudomonas aeruginosa. This review discusses the desirable characteristics of non-mammalian infection models and describes recent non-mammalian infection models that utilize Caenorhabditis elegans, silkworm, fruit fly, zebrafish, two-spotted cricket, hornworm, and waxworm.

    DOI: 10.1111/1348-0421.12834

    PubMed

    researchmap

  • Ligation of MHC Class II Induces PKC-Dependent Clathrin-Mediated Endocytosis of MHC Class II. Reviewed International journal

    Kento Masaki, Yuhji Hiraki, Hiroka Onishi, Yuka Satoh, Paul A Roche, Satoshi Tanaka, Kazuyuki Furuta

    Cells   9 ( 8 )   2020.7

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    In addition to antigen presentation to CD4+ T cells, aggregation of cell surface major histocompatibility complex class II (MHC-II) molecules induces signal transduction in antigen presenting cells that regulate cellular functions. We previously reported that crosslinking of MHC-II induced the endocytosis of MHC-II, which was associated with decreased surface expression levels in murine dendritic cells (DCs) and resulted in impaired activation of CD4+ T cells. However, the downstream signal that induces MHC-II endocytosis remains to be elucidated. In this study, we found that the crosslinking of MHC-II induced intracellular Ca2+ mobilization, which was necessary for crosslinking-induced MHC-II endocytosis. We also found that these events were suppressed by inhibitors of Syk and phospholipase C (PLC). Treatments with a phorbol ester promoted MHC-II endocytosis, whereas inhibitors of protein kinase C (PKC) suppressed crosslinking-induced endocytosis of MHC-II. These results suggest that PKC could be involved in this process. Furthermore, crosslinking-induced MHC-II endocytosis was suppressed by inhibitors of clathrin-dependent endocytosis. Our results indicate that the crosslinking of MHC-II could stimulate Ca2+ mobilization and induce the clathrin-dependent endocytosis of MHC-II in murine DCs.

    DOI: 10.3390/cells9081810

    PubMed

    researchmap

  • Extracellular ATP Augments Antigen-Induced Murine Mast Cell Degranulation and Allergic Responses via P2X4 Receptor Activation. Reviewed International journal

    Kazuki Yoshida, Masa-Aki Ito, Naoko Sato, Kosuke Obayashi, Kimiko Yamamoto, Schuichi Koizumi, Satoshi Tanaka, Kazuyuki Furuta, Isao Matsuoka

    Journal of immunology (Baltimore, Md. : 1950)   204 ( 12 )   3077 - 3085   2020.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Extracellular ATP released from stimulated and/or damaged cells modulates physiological responses via stimulation of various purinoceptors. We previously showed that ATP potentiated the Ag-induced mast cell (MC) degranulation via purinoceptors pharmacologically similar to the ionotropic P2X4 receptor. In this study, we investigated the role of P2X4 receptor in MC degranulation induced by stimulation of IgE-FcεRI complex with Ag, using bone marrow-derived MCs (BMMCs) prepared from wild type and P2X4 receptor-deficient (P2rx4-/- ) mice. ATP significantly increased Ag-induced degranulation in BMMCs prepared from wild type mice. This effect of ATP was reduced in BMMCs prepared from P2rx4-/- mice. The potentiating effect of ATP was restored by expressing P2X4 receptor in P2rx4-/- BMMCs. The P2X4 receptor-mediated effects were maintained even after differentiating into the connective tissue-type MCs. P2X4 receptor stimulation did not affect the Ag-induced Ca2+ response but enhanced Ag-induced early signals, such as tyrosine phosphorylation of Syk and phospholipase C-γ. Interestingly, these effects of ATP on Syk phosphorylation were not impaired by pretreatment with Cu2+, an inhibitor of the P2X4 receptor channel, or removal of external Ca2+, suggesting that a mechanisms other than Ca2+ influx through ion channel activity may be involved. In vivo experiments revealed that systemic and intradermal passive anaphylaxis responses were significantly alleviated in P2rx4-/- mice. Taken together, the present data suggest that the P2X4 receptor plays an essential role in ATP-induced upregulation of MC degranulation in response to Ag, and also contributes to the Ag-induced allergic response in vivo.

    DOI: 10.4049/jimmunol.1900954

    PubMed

    researchmap

  • Establishment and Characterization of a Murine Mucosal Mast Cell Culture Model. Reviewed International journal

    Aya Kakinoki, Tsuyoshi Kameo, Shoko Yamashita, Kazuyuki Furuta, Satoshi Tanaka

    International journal of molecular sciences   21 ( 1 )   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Accumulating evidence suggests that mast cells play critical roles in disruption and maintenance of intestinal homeostasis, although it remains unknown how they affect the local microenvironment. Interleukin-9 (IL-9) was found to play critical roles in intestinal mast cell accumulation induced in various pathological conditions, such as parasite infection and oral allergen-induced anaphylaxis. Newly recruited intestinal mast cells trigger inflammatory responses and damage epithelial integrity through release of a wide variety of mediators including mast cell proteases. We established a novel culture model (IL-9-modified mast cells, MCs/IL-9), in which murine IL-3-dependent bone-marrow-derived cultured mast cells (BMMCs) were further cultured in the presence of stem cell factor and IL-9. In MCs/IL-9, drastic upregulation of Mcpt1 and Mcpt2 was found. Although histamine storage and tryptase activity were significantly downregulated in the presence of SCF and IL-9, this was entirely reversed when mast cells were cocultured with a murine fibroblastic cell line, Swiss 3T3. MCs/IL-9 underwent degranulation upon IgE-mediated antigen stimulation, which was found to less sensitive to lower concentrations of IgE in comparison with BMMCs. This model might be useful for investigation of the spatiotemporal changes of newly recruited intestinal mast cells.

    DOI: 10.3390/ijms21010236

    PubMed

    researchmap

  • Identification of the minimal region of peptide derived from ADP-ribosylation factor1 (ARF1) that inhibits IgE-mediated mast cell activation. Reviewed International journal

    Ryota Uchida, Tomonori Egawa, Yoshio Fujita, Kazuyuki Furuta, Hiroaki Taguchi, Satoshi Tanaka, Keigo Nishida

    Molecular immunology   105   32 - 37   2019.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mast cells play a pivotal role in allergic reactions and inflammations. Aggregation of the high affinity IgE receptor (FcεRI) eventually leads to the release of granule components such as histamine, as well as the de novo synthesis of inflammatory cytokines and lipid mediators. These substances are involved in the development of allergy and inflammation. Therefore, efficient inhibitors of mast cell activation would be therapeutically beneficial. We previously demonstrated that the synthetic peptide derived from the NH2-terminal region (2-17: GNIFANLFKGLFGKKE) of a small GTPase ARF1 (ADP-ribosylation factor1) inhibited FcεRI-induced mast cell degranulation. However, detailed structure-activity relationship study of NH2-terminal portion of ARF1 peptide has not been done. In addition, it is still unclear whether the NH2-terminal peptide of ARF1 suppresses FcεRI-induced production of cytokines and lipid mediators such as leukotriene C4 (LTC4) from mast cells. Here we show that amino acid residues K10-K16 are necessary for ARF1 peptide to efficiently inhibit FcεRI-induced activation of bone marrow-derived mast cells (BMMCs), indicated by decreased mast cell degranulation, cytokine secretion and leukotriene release. Furthermore, we show that ARF1 peptide inhibits IgE-mediated passive cutaneous anaphylaxis reaction. Our results suggest that the peptide derived from ARF1 could be developed into a novel anti-allergic agent for therapeutic intervention in allergy and mast cell-related pathologies.

    DOI: 10.1016/j.molimm.2018.11.002

    PubMed

    researchmap

  • Suppression of IgE-Independent Degranulation of Murine Connective Tissue-Type Mast Cells by Dexamethasone. Reviewed

    Yamada K, Sato H, Sakamaki K, Kamada M, Okuno Y, Fukuishi N, Furuta K, Tanaka S

    Cells.   8 ( 2 )   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI  

    Steroidal anti-inflammatory drugs are widely used for the treatment of chronic cutaneous inflammation, such as atopic dermatitis, although it remains unknown how they modulate cutaneous mast cell functions. We investigated the effects of prolonged treatment with a synthetic glucocorticoid, dexamethasone, on murine connective tissue-type mast cells using in vitro and in vivo models. Our connective tissue-type bone marrow-derived cultured mast cell model was found to be sensitive to mast cell secretagogues, such as compound 48/80 and substance P, and higher expression levels of subunit of a trimeric G protein, G(i1), and several Mas-related G protein-coupled receptor (Mrgpr) subtypes were observed in comparison with immature cultured mast cells. Secretagogue-induced degranulation and up-regulation of these genes was suppressed when cultured in the presence of dexamethasone. The profiles of granule constituents were drastically altered by dexamethasone. Topical application of dexamethasone down-modulated secretagogue-induced degranulation and the expression levels of several Mrgpr subtypes in cutaneous tissue. These results suggest that mast cell-mediated IgE-independent cutaneous inflammation could be suppressed by steroidal anti-inflammatory drugs through the down-regulation of G (i1) and several Mrgpr subtypes in mast cells.

    DOI: 10.3390/cells8020112

    Web of Science

    researchmap

  • Neuromedin U directly induces degranulation of skin mast cells, presumably via MRGPRX2. Reviewed International journal

    Yoshimi Matsuo, Yuhki Yanase, Reiko Irifuku, Shunsuke Takahagi, Shoji Mihara, Kaori Ishii, Tomoko Kawaguchi, Akio Tanaka, Kazumasa Iwamoto, Haruka Watanuki, Kazuyuki Furuta, Satoshi Tanaka, Asuka Inoue, Junken Aoki, Michihiro Hide

    Allergy   73 ( 11 )   2256 - 2260   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/all.13555

    PubMed

    researchmap

  • Suppression of IFN-γ Production in Murine Splenocytes by Histamine Receptor Antagonists. Reviewed

    Kamei M, Otani Y, Hayashi H, Nakamura T, Yanai K, Furuta K, Tanaka S

    Int J Mol Sci.   19 ( 12 )   4083 - 4083   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Accumulating evidence suggests that histamine synthesis induced in several types of tumor tissues modulates tumor immunity. We found that a transient histamine synthesis was induced in CD11b+Gr-1+ splenocytes derived from BALB/c mice transplanted with a syngeneic colon carcinoma, CT-26, when they were co-cultured with CT-26 cells. Significant levels of IFN-γ were produced under this co-culture condition. We explored the modulatory roles of histamine on IFN-γ production and found that several histamine receptor antagonists, such as pyrilamine, diphenhydramine, JNJ7777120, and thioperamide, could significantly suppress IFN-γ production. However, suppression of IFN-γ production by these antagonists was also found when splenocytes were derived from the Hdc−/− BALB/c mice. Suppressive effects of these antagonists were found on IFN-γ production induced by concanavalin A or the combination of an anti-CD3 antibody and an anti-CD28 antibody in a histamine-independent manner. Murine splenocytes were found to express H1 and H2 receptors, but not H3 and H4 receptors. IFN-γ production in the Hh1r−/− splenocytes induced by the combination of an anti-CD3 antibody and an anti-CD28 antibody was significantly suppressed by these antagonists. These findings suggest that pyrilamine, diphenhydramine, JNJ7777120, and thioperamide can suppress IFN-γ production in activated splenocytes in a histamine-independent manner.

    DOI: 10.3390/ijms19124083

    researchmap

  • Vesicular Polyamine Transporter Mediates Vesicular Storage and Release of Polyamine from Mast Cells Reviewed

    Tomoya Takeuchi, Yuika Harada, Satomi Moriyama, Kazuyuki Furuta, Satoshi Tanaka, Takaaki Miyaji, Hiroshi Omote, Yoshinori Moriyama, Miki Hiasa

    JOURNAL OF BIOLOGICAL CHEMISTRY   292 ( 9 )   3909 - 3918   2017.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Mast cells are secretory cells that play an important role in host defense by discharging various intragranular contents, such as histamine and serotonin, upon stimulation of Fc receptors. The granules also contain spermine and spermidine, which can act as modulators of mast cell function, although the mechanism underlying vesicular storage remains unknown. Vesicular polyamine transporter (VPAT), the fourth member of the SLC18 transporter family, is an active transporter responsible for vesicular storage of spermine and spermidine in neurons. In the present study, we investigated whether VPAT functions in mast cells. RT-PCR and Western blotting indicated VPAT expression in murine bone marrow-derived mast cells (BMMCs). Immunohistochemical analysis indicated that VPAT is colocalized with VAMP3 but not with histamine, serotonin, cathepsin D, VAMP2, or VAMP7. Membrane vesicles from BMMCs accumulated spermidine upon the addition of ATP in a reserpine- and bafilomycin A(1)-sensitive manner. BMMCs secreted spermine and spermidine upon the addition of either antigen or A23187 in the presence of Ca2+, and the antigen-mediated release, which was shown to be temperature-dependent and sensitive to bafilomycin A(1) and tetanus toxin, was significantly suppressed by VPAT gene RNA interference. Under these conditions, expression of vesicular monoamine transporter 2 was unaffected, but antigen-dependent histamine release was significantly suppressed, which was recovered by the addition of 1 mm spermine. These results strongly suggest that VPAT is expressed and is responsible for vesicular storage of spermine and spermidine in novel secretory granules that differ from histamine- and serotonin-containing granules and is involved in vesicular release of these polyamines from mast cells.

    DOI: 10.1074/jbc.M116.756197

    Web of Science

    researchmap

  • 1-Fluoro-2,4-dinitrobenzene and its derivatives act as secretagogues on rodent mast cells Reviewed

    Yohei Manabe, Marie Yoshimura, Kazuma Sakamaki, Asuka Inoue, Aya Kakinoki, Satoshi Hokari, Mariko Sakanaka, Junken Aoki, Hiroyuki Miyachi, Kazuyuki Furuta, Satoshi Tanaka

    EUROPEAN JOURNAL OF IMMUNOLOGY   47 ( 1 )   60 - 67   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Accumulating evidence suggests that activated mast cells are involved in contact hypersensitivity, although the precise mechanisms of their activation are still not completely understood. We investigated the potential of common experimental allergens to induce mast cell activation using murine bone marrow-derived cultured mast cells and rat peritoneal mast cells. Among these allergens, 1-chloro-2,4-dinitrobenzene and 1-fluoro-2,4-dinirobenzene (DNFB) were found to induce degranulation of rat peritoneal mast cells. DNFB-induced degranulation is accompanied by cytosolic Ca2+ mobilization and is significantly inhibited by pertussis toxin, U73122 (a phospholipase C inhibitor), and BAPTA (a Ca2+ chelator), raising the possibility that DNFB acts on the G protein-coupled receptors and activates Gi, which induces activation of phospholipase C, as well as known mast cell secretagogues, such as compound 48/ 80. DNFB could induce mast cell degranulation in the absence of serum proteins and IgE. Structure-activity relationship analyses revealed an inverse correlation between the degree of degranulation and the electron density of the C1 carbon of the DNFB derivatives. These findings raise a possibility that DNFB functions as a potent contact allergen through induction of cutaneous mast cell degranulation.

    DOI: 10.1002/eji.201646536

    Web of Science

    researchmap

  • Down-modulation of antigen-induced activation of murine cultured mast cells sensitized with a highly cytokinergic IgE clone Reviewed

    Mariko Sakanaka, Yuki Kurimune, Keiko Yamada, Nao Hyodo, Mayuko Natsuhara, Atsushi Ichikawa, Kazuyuki Furuta, Satoshi Tanaka

    IMMUNOLOGY LETTERS   174   1 - 8   2016.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Accumulating evidence suggests that several IgE clones can activate mast cells during the sensitization phase even in the absence of antigen. They were found to induce pro-inflammatory cytokine release, histamine synthesis, chemotaxis, adhesion, and accelerated maturation of mast cells, although it remains unknown whether antigen-induced responses can be affected by differences of IgE clones. We compared two IgE clones, which were different in the capacity to activate mast cells during sensitization, in terms of potentials to affect antigen-induced degranulation and cytokine releases using IL-3-dependent murine bone marrow-derived cultured mast cells (BMMCs). Antigen-induced degranulation and pro-inflammatory cytokine release were augmented, when BMMCs were sensitized with elevated concentrations of a clone IgE-3, which did not induce phosphorylation of JNK and cytokine release in the absence of antigen, whereas those were significantly rather decreased, when BMMCs were sensitized with elevated concentrations of a clone SPE-7, one of the most potent cytokinergic IgE clones, which intensively induced phosphorylation of JNK. This attenuated response with SPE-7 was accompanied by decreased tyrosine phosphorylation of the cellular proteins including Syk upon antigen stimulation. SP600125, which is known to inhibit JNK, restored the levels of antigen-induced degranulation and phosphorylation of Syk in BMMCs sensitized with higher concentrations of a clone SPE-7 when it was added before sensitization. Treatment with anisomycin, a potent activator of JNK, before IgE sensitization significantly suppressed antigen-induced degranulation. These findings suggest that differences of sensitizing IgE clones can affect antigen-induced responses and activation of JNK during sensitization might suppress antigen-induced activation of mast cells. (C) 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.imlet.2016.04.003

    Web of Science

    researchmap

  • Cell Surface-Anchored Fluorescent Probe Capable of Real-Time Imaging of Single Mast Cell Degranulation Based on Histamine-Induced Coordination Displacement Reviewed

    Yuji Oshikawa, Kazuyuki Furuta, Satoshi Tanaka, Akio Ojida

    ANALYTICAL CHEMISTRY   88 ( 3 )   1526 - 1529   2016.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    Mast cells secrete histamine upon degranulation triggered by various stimuli. Herein, we report the new detection method of mast cell degranulation using the fluorescent probe capable of detection of the released histamine. The probe was designed as the Co(II) complex of a cyanine dye, which shows a turn-on fluorescence signal based on a histamine-induced coordination displacement mechanism. Fluorescence imaging using the cell surface-anchored fluorescent probe enabled the real-time detection of mast cell degranulation induced by various secretagogues.

    DOI: 10.1021/acs.analchem.5b04758

    Web of Science

    researchmap

  • The ins and outs of MHC class II-mediated antigen processing and presentation Reviewed

    Paul A. Roche, Kazuyuki Furuta

    NATURE REVIEWS IMMUNOLOGY   15 ( 4 )   203 - 216   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Antigenic peptide-loaded MHC class II molecules (peptide-MHC class II) are constitutively expressed on the surface of professional antigen-presenting cells (APCs), including dendritic cells, B cells, macrophages and thymic epithelial cells, and are presented to antigen-specific CD4(+) T cells. The mechanisms of antigen uptake, the nature of the antigen processing compartments and the lifetime of cell surface peptide-MHC class II complexes can vary depending on the type of APC. It is likely that these differences are important for the function of each distinct APC subset in the generation of effective adaptive immune responses. In this Review, we describe our current knowledge of the mechanisms of uptake and processing of antigens, the intracellular formation of peptide-MHC class II complexes, the intracellular trafficking of peptide-MHC class II complexes to the APC plasma membrane and their ultimate degradation.

    DOI: 10.1038/nri3818

    Web of Science

    researchmap

  • Histamine synthesis is required for granule maturation in murine mast cells Reviewed

    Shunsuke Nakazawa, Mariko Sakanaka, Kazuyuki Furuta, Mayuko Natsuhara, Hirotsugu Takano, Soken Tsuchiya, Yasushi Okuno, Hiroshi Ohtsu, Masahiro Nishibori, Robin L. Thurmond, Noriyasu Hirasawa, Kazuhisa Nakayama, Atsushi Ichikawa, Yukihiko Sugimoto, Satoshi Tanaka

    EUROPEAN JOURNAL OF IMMUNOLOGY   44 ( 1 )   204 - 214   2014.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    DOI: 10.1002/eji.201343838

    Web of Science

    researchmap

  • Regulation of histamine synthesis and tryptase expression through transcription factors, growth factor independent 1 (gfi1) and gfi1b, in murine cultured mast cells Reviewed

    Azusa Taura, Kazuyuki Furuta, Tomoko Yamaguchi, Kenji Kawabata, Satoshi Tanaka

    Biological and Pharmaceutical Bulletin   37 ( 1 )   81 - 86   2014.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1248/bpb.b13-00616

    Scopus

    PubMed

    researchmap

  • Internalizing MHC class II-peptide complexes are ubiquitinated in early endosomes and targeted for lysosomal degradation Reviewed

    Kazuyuki Furuta, Even Walseng, Paul A. Roche

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   110 ( 50 )   20188 - 20193   2013.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    As sentinels of the immune system, dendritic cells (DCs) continuously generate and turnover antigenic peptide-MHC class II complexes (pMHC-II). pMHC-II generation is a complex process that involves many well-characterized MHC-II biosynthetic intermediates; however, the mechanisms leading to MHC-II turnover/degradation are poorly understood. We now show that pMHC-II complexes undergoing clathrin-independent endocytosis from the DC surface are efficiently ubiquitinated by the E3 ubiquitin ligase March-I in early endosomes, whereas biosynthetically immature MHC-II-Invariant chain (Ii) complexes are not. The inability of MHC-II-Ii to serve as a March-I substrate is a consequence of Ii sorting motifs that divert the MHC-II-Ii complex away from March-I+ early endosomes. When these sorting motifs are mutated, or when clathrin-mediated endocytosis is inhibited, MHC-II-Ii complexes internalize by using a clathrin-independent endocytosis pathway and are now ubiquitinated as efficiently as pMHC-II complexes. These data show that the selective ubiquitination of internalizing surface pMHC-II in March-I+ early endosomes promotes degradation of "old" pMHC-II and spares forms of MHC-II that have not yet loaded antigenic peptides or have not yet reached the DC surface.

    DOI: 10.1073/pnas.1312994110

    Web of Science

    researchmap

  • Acceleration of alcohol metabolism by Crassostera gigas extract

    Zhong Ming, Yoshio Shimizu, Kazuyuki Furuta, Satoshi Tanaka, Eiichi Gohda

    Japanese Pharmacology and Therapeutics   41 ( 4 )   319 - 321   2013

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    Oral administration of the water extract of Crassostera gigas (1 g/kg body weight, 30 min before) significantly suppressed the elevation of blood ethanol and acetaldehyde levels after the administration of ethanol (4 g/kg) in male Wistar rats (6 weeks of age), indicating that the Crassostera gigas extract should contain some active constituents that accelerate alcohol metabolism in the rats.

    Scopus

    researchmap

  • Anti-obesity effects of the fermented wheat extract with Bacillus subtilis (natto) strain DC15 (DC15-FE) on mice fed a high-fat diet

    Zhong Ming, Yoshio Shimizu, Kenji Osaki, Kazuyuki Furuta, Satoshi Tanaka

    Japanese Pharmacology and Therapeutics   41 ( 10 )   959 - 962   2013

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    Anti-obesity effects of the fermented wheat extracts with Bacillus subtilis (natto) strain DC15 (DC15-FE) were investigated using mice fed a high-fat diet. Body weights, the amount of abdominal visceral fat, and blood concentrations of triglyceride and glucose were significantly decreased in mice fed a high-fat diet containing 5% DC15-FE. These results suggest that DC15-FE have anti-obesity effects on a high-fat diet conditions.

    Scopus

    researchmap

  • Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells Reviewed

    Kazuyuki Furuta, Satoshi Ishido, Paul A. Roche

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   109 ( 47 )   19380 - 19385   2012.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    Major histocompatibility complex class II molecules (MHC-II) on antigen presenting cells (APCs) engage the TCR on antigen-specific CD4 T cells, thereby providing the specificity required for T cell priming and the induction of an effective immune response. In this study, we have asked whether antigen-loaded dendritic cells (DCs) that have been in contactwith antigen-specific CD4 T cells retain the ability to stimulate additional naive T cells. We show that encounter with antigen-specific primed CD4 T cells induces the degradation of surface MHC-II in antigen-loaded DCs and inhibits the ability of these DCs to stimulate additional naive CD4 T cells. Cross-linking with MHC-II mAb as a surrogate for T-cell engagement also inhibits APC function and induces MHC-II degradation by promoting the clustering of MHC-II present in lipid raft membrane microdomains, a process that leads to MHC-II endocytosis and degradation in lysosomes. Encounter of DCs with antigen-specific primed T cells or engagement of MHC-II with antibodies promotes the degradation of both immunologically relevant and irrelevant MHC-II molecules. These data demonstrate that engagement of MHC-II on DCs after encounter with antigen-specific primed CD4 T cells promotes the down-regulation of cell surface MHC-II in DCs, thereby attenuating additional activation of naive CD4 T cells by these APCs.

    DOI: 10.1073/pnas.1213868109

    Web of Science

    researchmap

  • Restriction of Mast Cell Proliferation through Hyaluronan Synthesis by Co-cultured Fibroblasts Reviewed

    Hirotsugu Takano, Kazuyuki Furuta, Kazuhito Yamashita, Mariko Sakanaka, Naoki Itano, Eiichi Gohda, Kazuhisa Nakayama, Koji Kimata, Yukihiko Sugimoto, Atsushi Ichikawa, Satoshi Tanaka

    BIOLOGICAL & PHARMACEUTICAL BULLETIN   35 ( 3 )   408 - 412   2012.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PHARMACEUTICAL SOC JAPAN  

    Appropriate culture models for tissue mast cells are required to determine how they are involved in regulation of local immune responses. We previously established a culture model for cutaneous mast cells, in which bone marrow-derived immature mast cells were co-cultured with Swiss 3T3 fibroblasts in the presence of stem cell factor. In this study, we focused on the roles of hyaluronan, which is produced by the feeder fibroblasts and forms the extracellular matrix during the co-culture period. Hyaluronan synthesis was found to be mediated by hyaluronan synthase 2 (HAS2) expressed in Swiss 3T3 cells. A decreases in the amount of hyaluronan, which was achieved by retroviral expression of short hairpin RNA for Has2 or by addition of hyaluronidase, significantly enhanced the proliferation of the cultured mast cells without any obvious effects on their maturation. Although we previously demonstrated that CD44 is required for proliferation of cutaneous mast cells, the deficiency of hyaluronan did not affect the proliferation of the cultured mast cells that lack CD44. These findings suggest that the extracellular matrix containing hyaluronan may have a potential to restrict proliferation of cutaneous mast cells in a CD44-independent manner.

    DOI: 10.1248/bpb.35.408

    Web of Science

    researchmap

  • Dendritic Cell Activation Prevents MHC Class II Ubiquitination and Promotes MHC Class II Survival Regardless of the Activation Stimulus Reviewed

    Even Walseng, Kazuyuki Furuta, Romina S. Goldszmid, Karis A. Weih, Alan Sher, Paul A. Roche

    JOURNAL OF BIOLOGICAL CHEMISTRY   285 ( 53 )   41749 - 41754   2010.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    The expression of MHC class II (MHC-II) on the surface of antigen-presenting cells, such as dendritic cells (DCs), is tightly regulated during cellular activation. Many cells, including DCs, are activated following stimulation of innate Toll-like receptors (TLRs) by products of microorganisms. In the resting (immature) state, MHC-II is ubiquitinated in immature DCs and is rapidly degraded; however, after activation of these cells with MyD88-dependent TLR ligands, MHC-II ubiquitination is blocked, and MHC-II survival is prolonged. We now show that DC activation using MyD88-dependent TLR ligands, MyD88-independent TLR ligands, and even infection with the intracellular parasite Toxoplasma gondii leads to identical changes in MHC-II expression, ubiquitination, and surface stability, revealing a conserved role for enhanced MHC-II stability after DC activation by different stimuli.

    DOI: 10.1074/jbc.M110.157586

    Web of Science

    researchmap

  • Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells Reviewed

    Even Walseng, Kazuyuki Furuta, Berta Bosch, Karis A. Weih, Yohei Matsuki, Oddmund Bakke, Satoshi Ishido, Paul A. Roche

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   107 ( 47 )   20465 - 20470   2010.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    The expression and turnover of MHC class II-peptide complexes (pMHC-II) on the surface of dendritic cells (DCs) is essential for their ability to activate CD4 T cells efficiently. The half-life of surface pMHC-II is significantly greater in activated (mature) DCs than in resting (immature) DCs, but the molecular mechanism leading to this difference remains unknown. We now show that ubiquitination of pMHC-II by the E3 ubiquitin ligase membrane-associated RING-CH 1 (March-I) regulates surface expression, intracellular distribution, and survival of pMHC-II in DCs. DCs isolated from MarchI- KO mice express very high levels of pMHC-II on the plasma membrane even before DC activation. Although ubiquitination does not affect the kinetics of pMHC-II endocytosis from the surface of DCs, the survival of pMHC-II is enhanced in DCs obtained from March-I-deficient and MHC-II ubiquitination-mutant mice. Using pMHC-II-specific mAb, we show that immature DCs generate large amounts of pMHC-II that are remarkably stable under conditions in which pMHC-II ubiquitination is blocked. Thus, the cellular distribution and stability of surface pMHC-II in DCs is regulated by ubiquitin-dependent degradation of internalized pMHC-II.

    DOI: 10.1073/pnas.1010990107

    Web of Science

    researchmap

  • Impaired activation of mast cells upon IgE-mediated antigen stimulation in a stroke-prone spontaneously hypertensive rat strain, SHRSP.Z Reviewed

    Mariko Sakanaka, Kazuyuki Furuta, Atsushi Ichikawa, Satoshi Tanaka

    IMMUNOLOGY LETTERS   128 ( 1 )   74 - 79   2010.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    We investigated IgE-mediated allergic responses in a metabolic syndrome model rat strain, SHRSP.Z, which develops obesity and hypertension to cast light on the relationship between metabolic disturbances and allergic responses. IgE-mediated cutaneous anaphylactic responses were severely attenuated in this strain regardless of the presence of fa/fa mutation, compared with the parental WKY/Izm strain. Furthermore, in the peritoneal mast cells of both the SHRSP.Z and SHRSP/Izm strains, IgE-mediated activation, such as degranulation and protein tyrosine phosphorylation, was severely impaired whereas no significant differences were found in morphology and number of peritoneal mast cells. Immunoblot analyses revealed that phosphorylation levels of Syk upon IgE-mediated antigen stimulation were significantly decreased and basal expression of linker for activation of T cells (LAT) was down-regulated in peritoneal mast cells of the SHRSP strains. These results suggest that attenuated cutaneous allergic responses in the SHRSP.Z strain might be attributed to impaired Fc epsilon RI-mediated signal transduction in mast cells. (C) 2009 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.imlet.2009.11.007

    Web of Science

    researchmap

  • Involvement of CD44 in mast cell proliferation during terminal differentiation Reviewed

    Hirotsugu Takano, Shunsuke Nakazawa, Naritoshi Shirata, Shigero Tamba, Kazuyuki Furuta, Sohken Tsuchiya, Kazushi Morimoto, Naoki Itano, Atsushi Irie, Atsushi Ichikawa, Koji Kimata, Kazuhisa Nakayama, Yukihiko Sugimoto, Satoshi Tanaka

    LABORATORY INVESTIGATION   89 ( 4 )   446 - 455   2009.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    By using the recently established culture system that reproduces the terminal differentiation process of connective tissue-type mast cells, we found significant transcriptional induction of CD44. As CD44 is a primary receptor for hyaluronan (HA), which is one of the major extracellular matrix components, we investigated the role of CD44 in cutaneous mast cells. When co-cultured with fibroblasts, mouse bone marrow-derived cultured mast cells (BMMCs) were found to form clusters in an HA-dependent manner. As compared with BMMCs derived from the wild-type mice, those from the CD44(-/-) mice exhibited impaired growth during the co-cultured period. Furthermore, in the peritoneal cavities and ear tissues, mature mast cells were fewer in number in the CD44(-/-) mice than in the wild-type mice. We investigated roles of CD44 in mast cell proliferation by reconstituting BMMCs into the tissues of mast cell-deficient, Kit(W)/Kit(W-v) mice, and found that the number of metachromatic cells upon acidic toluidine blue staining in the tissues transplanted with CD44(-/-) BMMCs was not significantly changed for 10 weeks, whereas that in the tissues transplanted with the CD44(+/+) BMMCs was significantly increased. These results suggest that CD44 plays a crucial role in the regulation of the cutaneous mast cell number.

    DOI: 10.1038/labinvest.2008.159

    Web of Science

    researchmap

  • Establishment of the culture model system that reflects the process of terminal differentiation of connective tissue-type mast cells Reviewed

    Hirotsugu Takano, Shunsuke Nakazawa, Yasushi Okuno, Naritoshi Shirata, Sohken Tsuchiya, Takayuki Kainoh, Seigoh Takamatsu, Kazuyuki Furuta, Yoshitaka Taketomi, Yuko Naito, Hiromu Takematsu, Yasunori Kozutsumi, Gozoh Tsujimoto, Makoto Murakami, Ichiro Kudo, Atsushi Ichikawa, Kazuhisa Nakayama, Yukihiko Sugimoto, Satoshi Tanaka

    FEBS LETTERS   582 ( 10 )   1444 - 1450   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    To understand physiological roles of tissue mast cells, we established a culture system where bone marrow-derived immature mast cells differentiate into the connective tissue-type mast cell (CTMC)-like cells through modifying the previous co-culture system with Swiss 3T3 fibroblasts. Our system was found to reproducibly mimic the differentiation of CTMCs on the basis of several criteria, such as granule maturation and sensitivity to cationic secretagogues. The gene expression pro. le obtained by the microarray analyses was found to reflect many aspects of the differentiation. Our system is thus helpful to gain deeper insights into terminal differentiation of CTMCs. (C) 2008 Published by Elsevier B. V. on behalf of the Federation of European Biochemical Societies.

    DOI: 10.1016/j.febslet.2008.03.033

    Web of Science

    researchmap

  • Activation of histidine decarboxylase through post-translational cleavage by caspase-9 in a mouse mastocytoma P-815 Reviewed

    Kazuyuki Furuta, Kazuhisa Nakayama, Yukihiko Sugimoto, Atsushi Ichikawa, Satoshi Tanaka

    JOURNAL OF BIOLOGICAL CHEMISTRY   282 ( 18 )   13438 - 13446   2007.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    (L)-Histidine decarboxylase (HDC) is the rate-limiting enzyme for histamine synthesis in mammals. Although accumulating evidence has indicated the post-translational processing of HDC, it remains unknown what kinds of proteases are involved. We investigated the processing of HDC in a mouse mastocytoma, P-815, using a lentiviral expression system. HDC was expressed as a 74-kDa precursor form, which is cleaved to yield the 55- and 60-kDa forms upon treatment with butyrate. Alanine-scanning mutations revealed that two tandem aspartate residues (Asp(517) -Asp(518), Asp(550)- Asp(551)) are critical for the processing. Treatment with butyrate caused an increase in the enzyme activity of the cells expressing the wild type HDC, but not in the cells expressing the processing-incompetent mutant. An increase in histamine synthesis by butyrate was accompanied by formation of the 55- and 60-kDa form of HDC. In addition, the in vitro translated 74-kDa form of HDC was found to undergo a limited cleavage by purified human caspase-9, whereas the alanine-substituted mutants were not. Processing and enzymatic activation of HDC in P-815 cells was enhanced in the presence of a Zn2+ chelator, TPEN. Although treatment with butyrate and TPEN drastically augmented the protease activity of caspase-3, and -9, no apoptotic cell death was observed. Both enzymatic activation and processing of HDC were completely suppressed by a pan-caspase inhibitor, partially but significantly by a specific inhibitor for caspase-9, but not by a caspase-3 inhibitor. These results suggest that, in P-815 cells, histamine synthesis is augmented through the post-translational cleavage of HDC, which is mediated by caspase-9.

    DOI: 10.1074/jbc.M609943200

    Web of Science

    researchmap

  • Membrane orientation of the precursor 74-kDa form of L-histidine decarboxylase Reviewed

    K Furuta, A Ichikawa, K Nakayama, S Tanaka

    INFLAMMATION RESEARCH   55 ( 5 )   185 - 191   2006.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIRKHAUSER VERLAG AG  

    Objective: We previously demonstrated that, when expressed in COS-7 cells, L-histidine decarboxylase (HDC), which has neither an amino terminal signal sequence nor a hydrophobic membrane anchor, was localized in the endoplasmic reticulum (ER), although its orientation in the membrane remains to be clarified.
    Methods & Results: Protease digestion and immunofluorescence analyses of the cells, of which plasma membrane was selectively permeabilized, revealed that the amino terminal 50-kDa portion of HDC is hardly accessible to proteases and antibodies added exogenously from the cytosolic side. Green fluorescent protein fused with the carboxyl terminal 20-kDa region of HDC at its carboxyl terminus exhibited the same characteristics as native HDC.
    Conclusion: These results indicate that HDC is tightly associated with the ER membrane with its carboxyl terminal region exposed on the cytosolic side.

    DOI: 10.1007/s00011-006-0069-x

    Web of Science

    researchmap

  • Critical role of protein kinase C beta II in activation of mast cells by monomeric IgE Reviewed

    Y Liu, K Furuta, R Teshima, N Shirata, Y Sugimoto, A Ichikawa, S Tanaka

    JOURNAL OF BIOLOGICAL CHEMISTRY   280 ( 47 )   38976 - 38981   2005.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Accumulating evidence suggests that IgE-mediated activation of mast cells occurs even in the absence of antigen, which is referred to as "monomeric IgE" responses. Although monomeric IgE was found to induce a wide variety of responses, such as up-regulation of the Fc epsilon RI, survival, cytokine production, histamine synthesis, and adhesion to fibronectin, it remains to be clarified how mast cells are activated in the absence of antigen. It has been controversial whether monomeric IgE responses are mediated by a similar signaling mechanism to antigen stimulation, although recent studies suggest that IgE can induce the Fc epsilon RI aggregation even in the absence of antigen. In this study, we focused on the role of conventional protein kinase C (cPKC), since this response is suppressed by a specific inhibitor for cPKC. Monomeric IgE-induced Ca2+ influx was not observed in a mouse mastocytoma cell line, which lacks the expression of PKC beta II, although Ca2+ influx induced by cross-linking of the Fc epsilon RI was intact. Transfection of PKC beta II cDNA was found to restore the Ca2+ influx induced by monomeric IgE in this cell line. Furthermore, the dominant negative form of PKC beta II (PKC beta II/T500V) significantly suppressed the Ca2+ influx, histamine synthesis, and interleukin-6 production in another mouse mast cell line, which is highly sensitive to monomeric IgE. Expression of PKC beta II/T500V was found not to affect the antigen-induced responses. These results suggest that PKC beta II plays a critical role in monomeric IgE responses, but not in antigen responses.

    DOI: 10.1074/jbc.M506351200

    Web of Science

    researchmap

  • Histamine H-2 receptor-mediated modulation of local cytokine expression in a mouse experimental tumor model Reviewed

    K Takahashi, S Tanaka, K Furuta, A Ichikawa

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   297 ( 5 )   1205 - 1210   2002.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Accumulating evidence indicates that histamine is involved in the modulation of cytokine expression patterns. We previously reported that daily treatment with the H-2 receptor antagonist, cimetidine, suppressed tumor growth through alteration of the local cytokine expression pattern. In this study, we used a mouse strain genetically lacking histidine decarboxylase (HDC), to evaluate the role of endogenous histamine synthesis on cytokine expression and tumor development. In the mutant mice, cimetidine had no effect on tumor growth, whereas an H-2 agonist, dimaprit, significantly enhanced tumor growth. When the HDC-deficient mice were implanted with mutant CT-26 cells stably expressing HDC, drastic suppression of tumor growth by cimetidine was observed, which was accompanied by augmentation of mRNA expression of LT-beta, TNF-alpha, and IFN-gamma in the tumor tissues. These results suggest that endogenous histamine synthesis in tumor tissues suppresses local tumor immunity via the H2 receptors, resulting in tumor growth promotion. (C) 2002 Elsevier Science (USA). All rights reserved.

    DOI: 10.1016/S0006-291X(02)02360-4

    Web of Science

    researchmap

▼display all

Books

  • Heat Shock Proteins in Human Diseases

    Kazuyuki Furuta, Taka Eguchi( Role: Contributor ,  Roles of HSP on Antigen Presentation)

    2020.7 

     More details

MISC

  • GPR35を介したマスト細胞の脱顆粒応答抑制機構の解明

    水粉 翔也, 古田 和幸, 井上 飛鳥, 青木 淳賢, 田中 智之

    日本生化学会大会プログラム・講演要旨集   89回   [3T16 - 04(2P   2016.9

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • IgE非依存的なマスト細胞活性化に対するデキサメタゾンの作用

    田中智之, 山田圭位子, 佐藤仁美, 鎌田真由美, 奥野恭史, 福石信之, 古田和幸

    日本ヒスタミン学会プログラム・講演要旨集   20th   32   2016

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Ubiquitination by march-I prevents pMHC-II recycling

    Kyung-Jin Cho, Kazuyuki Furuta, Even Walseng, Paul A. Roche

    MOLECULAR IMMUNOLOGY   68 ( 2 )   149 - 150   2015.12

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Web of Science

    researchmap

  • ヒスタミンとアナフィラキシー (特集 アナフィラキシス)

    田中 智之, 古田 和幸

    アレルギー・免疫   20 ( 8 )   1150 - 1154   2013.8

     More details

    Language:Japanese   Publisher:医薬ジャーナル社  

    CiNii Article

    CiNii Books

    researchmap

  • MHC-II crosslinking promotes lipid-raft dependent MHC-II clustering, endocytosis, and degradation in dendritic cells

    Paul Roche, Kazuyuki Furuta, Satoshi Ishido

    MOLECULAR IMMUNOLOGY   51 ( 1 )   29 - 29   2012.5

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    DOI: 10.1016/j.molimm.2012.02.078

    Web of Science

    researchmap

  • Encounter with antigen-specific CD4 T cells promotes down-regulation of MHC-II in Dendritic cells

    Kazuyuki Furuta, Satoshi Ishido, Paul Roche

    JOURNAL OF IMMUNOLOGY   188   2012.5

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    Web of Science

    researchmap

▼display all

Research Projects

  • 樹状細胞の抗原提示プロセスに対する細菌の作用の解明

    Grant number:23K06130  2023.04 - 2026.03

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    古田 和幸, 垣内 力

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    researchmap

  • Investigation of bacterial virulence potential at the molecular level

    Grant number:22H02869  2022.04 - 2025.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    垣内 力, 寺尾 豊, 古田 和幸

      More details

    Grant amount:\17420000 ( Direct expense: \13400000 、 Indirect expense:\4020000 )

    researchmap

  • 樹状細胞における細胞周辺環境に応じた抗原提示分子の発現制御メカニズムの解明

    Grant number:20K07030  2020.04 - 2023.03

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    古田 和幸

      More details

    Grant amount:\4290000 ( Direct expense: \3300000 、 Indirect expense:\990000 )

    樹状細胞は生体に侵入した病原細菌や腫瘍由来成分などの外来抗原を取り込み、主要組織適合抗原(MHC)分子を介して外来抗原由来ペプチドを T細胞に提示することで病原細菌や腫瘍に対する免疫応答を誘導する。この抗原提示においては、MHC-I、MHC-IIの発現と共に、活性化因子であるCD80, CD86などの共刺激分子、また抑制因子であるPD-L1、PD-L2などの共抑制分子の細胞表面発現がT細胞の活性化を調節する。樹状細胞の周辺環境の因子はこれらのタンパク質の細胞表面発現の変化を誘導することで樹状細胞による抗原提示機能を変化させると考えられている。
    樹状細胞は抗腫瘍免疫応答の誘導においては腫瘍由来抗原ペプチドを提示することで腫瘍に対する免疫応答が開始されるが、腫瘍細胞や腫瘍周辺細胞の産生する因子は樹状細胞の抗原提示機能に対して抑制的に作用することが知られている。腫瘍などの疾患状態においては、免疫細胞に小胞体ストレスが誘導され、免疫機能に抑制的に作用することも報告されているが、この抑制機構についてはどのような因子がどのように機能するかは明らかではない。そこで、本研究では、腫瘍周辺環境に由来する因子などの樹状細胞の周辺環境からの刺激対する抗原提示関連分子の発現制御機構の解明を目的として解析を行い、今年度は以下の結果を得た。
    1) 腫瘍の培養上清は樹状細胞表面の接着分子の発現を変化させることを見いだした。
    2) 小胞体ストレス誘導刺激によって樹状細胞表面の抗原提示分子の発現が抑制されることを見いだした。

    researchmap

  • Elucidation of liver mitochondrial failure and autoinflammation with RNA-epigenetics caused by nutrient stress

    Grant number:19K11692  2019.04 - 2022.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    TAKAYAMA Fusako

      More details

    Grant amount:\4290000 ( Direct expense: \3300000 、 Indirect expense:\990000 )

    Inadequate diets (high fat and high sugar diets, overeating habit) are well known as the nutrient stress to develop metabolic syndrome related diseases including NAFLD/NASH (excessive triglyceride accumulation in hepatocytes [ectopic fat morbidity]).
    Using NAFLD/NASH model [Japanese Patent No.5109134] rats, we exhibited for the first time that changes in 1) RNA methylation degree and 2) ALKBH expression, 3) inflammasome complex formation, in hepatocytes of rats. These results had high correlations with the mitochondrial metabolism failure, oxidative stress and the NAFLD/NASH severity. According to other advance studies with cell experiments, the RNA-epigenetics with 1) and 2) have abilities to reform inflammasome complex and mitochondria function. In summary, the RNA-epigenetics responded to the nutrient stress, could link to mitochondrial disorder and chronic inflammation, the common roots to exacerbate metabolic syndrome related diseases including NAFLD/NASH.

    researchmap

  • 多様なRNA相互作用因子を介したグラム陽性細菌の病原性制御機構の解明

    2019 - 2021

    日本学術振興会  基盤研究(B) 

    垣内 力

      More details

    Grant type:Competitive

    researchmap

  • 樹状細胞の活性化を誘導する細胞外危険シグナルによる抗腫瘍免疫誘導

    2019

    小柳財団  研究助成 

    古田 和幸

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 腫瘍による樹状細胞の抑制機構の解明

    2018

    鈴木謙三記念医科学応用研究財団  研究助成 

    古田 和幸

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 活性化樹状細胞の抗原提示レベルを制御する細胞内小胞輸送機構の解明

    2017 - 2019

    日本学術振興会  基盤研究(C) 

    古田 和幸

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 樹状細胞の抗原提示を制御するRabタンパク質の解析

    2015 - 2016

    日本学術振興会  若手研究(B) 

    古田 和幸

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 樹状細胞の抗原提示を制御する小胞輸送機構の解明

    2015

    武田科学振興財団  薬学奨励研究 

    古田 和幸

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 新たな創薬標的としての脳内マスト細胞

    2014 - 2015

    日本学術振興会  挑戦的萌芽研究 

    田中 智之

      More details

    Grant type:Competitive

    researchmap

  • 細胞内小胞輸送を介する主要組織適合抗原クラスII発現調節機構の解明

    2013 - 2014

    日本学術振興会  若手研究(B) 

    古田 和幸

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • T細胞受容体との相互作用による主要組織適合抗原複合体クラスIIの樹状細胞表面発現抑制の分子機構の解明

    2013

    両備檉園記念財団  研究助成金 

    古田 和幸

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

▼display all

 

Class subject in charge

  • How Do Medicines Work ? (2024academic year) Fourth semester  - 木1~2

  • Immunology 1 (2024academic year) 1st semester  - 月3~4

  • Immunology 1 (2024academic year) 1st semester  - 月3~4

  • Immunology 2 (2024academic year) Second semester  - 月3~4

  • Immunology 2 (2024academic year) Second semester  - 月3~4

  • Immunology 3 (2024academic year) Third semester  - 月3~4

  • Immunology 3 (2024academic year) Third semester  - 月3~4

  • Immunology A (2024academic year) 1st and 2nd semester  - 月3~4

  • Immunology A (2024academic year) 1st and 2nd semester  - 月3~4

  • Immunology B (2024academic year) Third semester  - 月3~4

  • Immunology B (2024academic year) Third semester  - 月3~4

  • Advanced Lectures: Molecular Biology (2024academic year) special  - その他

  • Advanced Seminars in Drug Discovery and Drug Development (Regulation of Biological Reponses) (2024academic year) special  - その他

  • Life science for drug discovery (2024academic year) Third semester  - 木5~6

  • Regulation of Biological Reponses (2024academic year) special  - その他

  • Regulation of Biological Reponses (2024academic year) special  - その他

  • Seminar on Regulation of Biological Reponses (2024academic year) special  - その他

  • Regulation of Biological Responses I (2024academic year) special  - その他

  • Regulation of Biological Responses II (2024academic year) special  - その他

  • Life Science and Molecular Cell Biology (2024academic year) special  - その他

  • Life Science 1 (2024academic year) special  - その他

  • Experimental Molecular Biology (2024academic year) Second semester  - その他5~9

  • Experimental Molecular Biology (2024academic year) Second semester  - その他5~9

  • Cell Biology 2 (2024academic year) Fourth semester  - 水3~4

  • Cell Biology 2 (2024academic year) Fourth semester  - 水3~4

  • Cell Biology B (2024academic year) Fourth semester  - 水3~4

  • Cell Biology B (2024academic year) Fourth semester  - 水3~4

  • Practice in Fundamental Pharmaceutical Sciences III (2024academic year) Second semester  - その他5~9

  • Practice in Fundamental Pharmaceutical Sciences III (2024academic year) Second semester  - その他5~9

  • Practice in Fundamental Pharmaceutical Sciences III (2024academic year) Second semester  - その他5~9

  • Practice in Fundamental Pharmaceutical Sciences III (2024academic year) Second semester  - その他5~9

  • How Do Medicines Work ? (2023academic year) Fourth semester  - 木1~2

  • Immunology 1 (2023academic year) 1st semester  - 月3~4

  • Immunology 1 (2023academic year) 1st semester  - 月3~4

  • Immunology 2 (2023academic year) Second semester  - 月3~4

  • Immunology 2 (2023academic year) Second semester  - 月3~4

  • Immunology 3 (2023academic year) Third semester  - 月3~4

  • Immunology 3 (2023academic year) Third semester  - 月3~4

  • Immunology A (2023academic year) 1st and 2nd semester  - 月3~4

  • Immunology A (2023academic year) 1st and 2nd semester  - 月3~4

  • Immunology B (2023academic year) Third semester  - 月3~4

  • Immunology B (2023academic year) Third semester  - 月3~4

  • Advanced Lectures: Molecular Biology (2023academic year) special  - その他

  • Advanced Seminars in Drug Discovery and Drug Development (Regulation of Biological Reponses) (2023academic year) special  - その他

  • Life science for drug discovery (2023academic year) Third semester  - 木5~6

  • Regulation of Biological Reponses (2023academic year) special  - その他

  • Regulation of Biological Reponses (2023academic year) special  - その他

  • Seminar on Regulation of Biological Reponses (2023academic year) special  - その他

  • Regulation of Biological Responses I (2023academic year) special  - その他

  • Regulation of Biological Responses II (2023academic year) special  - その他

  • Life Science and Molecular Cell Biology (2023academic year) special  - その他

  • Life Science 1 (2023academic year) special  - その他

  • Experimental Molecular Biology (2023academic year) Second semester  - その他5~9

  • Experimental Molecular Biology (2023academic year) Second semester  - その他5~9

  • Cell Biology 2 (2023academic year) Fourth semester  - 水3~4

  • Cell Biology 2 (2023academic year) Fourth semester  - 水3~4

  • Cell Biology B (2023academic year) Fourth semester  - 水3~4

  • Cell Biology B (2023academic year) Fourth semester  - 水3~4

  • Practice in Fundamental Pharmaceutical Sciences III (2023academic year) Second semester  - その他5~9

  • Practice in Fundamental Pharmaceutical Sciences III (2023academic year) Second semester  - その他5~9

  • Practice in Fundamental Pharmaceutical Sciences III (2023academic year) Second semester  - その他5~9

  • Practice in Fundamental Pharmaceutical Sciences III (2023academic year) Second semester  - その他5~9

  • How Do Medicines Work ? (2022academic year) Fourth semester  - 木1~2

  • Immunology 1 (2022academic year) 1st semester  - 月3~4

  • Immunology 1 (2022academic year) 1st semester  - 月3~4

  • Immunology 2 (2022academic year) Second semester  - 月3~4

  • Immunology 2 (2022academic year) Second semester  - 月3~4

  • Immunology 3 (2022academic year) Third semester  - 月3~4

  • Immunology 3 (2022academic year) Third semester  - 月3~4

  • Life science for drug discovery (2022academic year) Third semester  - 木5~6

  • Regulation of Biological Reponses (2022academic year) special  - その他

  • Seminar on Regulation of Biological Reponses (2022academic year) special  - その他

  • Regulation of Biological Responses I (2022academic year) special  - その他

  • Regulation of Biological Responses II (2022academic year) special  - その他

  • Life Science 1 (2022academic year) special  - その他

  • Cell Biology 2 (2022academic year) Fourth semester  - 火5~6

  • Cell Biology 2 (2022academic year) Fourth semester  - 火5~6

  • Cell Biology B (2022academic year) Fourth semester  - 火5~6

  • Cell Biology B (2022academic year) Fourth semester  - 火5~6

  • Practice in Fundamental Pharmaceutical Sciences III (2022academic year) Second semester  - その他5~9

  • Practice in Fundamental Pharmaceutical Sciences III (2022academic year) Second semester  - その他5~9

  • Practice in Fundamental Pharmaceutical Sciences III (2022academic year) Second semester  - その他5~9

  • Practice in Fundamental Pharmaceutical Sciences III (2022academic year) Second semester  - その他5~9

  • How Do Medicines Work ? (2021academic year) Fourth semester  - 木1~2

  • Immunology 1 (2021academic year) 1st semester  - 月3,月4

  • Immunology 1 (2021academic year) 1st semester  - 月3,月4

  • Immunology 2 (2021academic year) Second semester  - 月3,月4

  • Immunology 2 (2021academic year) Second semester  - 月3,月4

  • Immunology 3 (2021academic year) Third semester  - 月3,月4

  • Immunology 3 (2021academic year) Third semester  - 月3,月4

  • Life science for drug discovery (2021academic year) Third semester  - 木5~6

  • Regulation of Biological Reponses (2021academic year) special  - その他

  • Seminar on Regulation of Biological Reponses (2021academic year) special  - その他

  • Life Science 1 (2021academic year) Prophase  - その他

  • Cell Biology 2 (2021academic year) Fourth semester  - 火5,火6

  • Cell Biology 2 (2021academic year) Fourth semester  - 火5,火6

  • Cell Biology B (2021academic year) Fourth semester  - 火5,火6

  • Cell Biology B (2021academic year) Fourth semester  - 火5,火6

  • Practice in Fundamental Pharmaceutical Sciences III (2021academic year) Second semester  - その他6~9

  • Practice in Fundamental Pharmaceutical Sciences III (2021academic year) Second semester  - その他6~9

  • Practice in Fundamental Pharmaceutical Sciences III (2021academic year) Second semester  - その他6~9

  • Practice in Fundamental Pharmaceutical Sciences III (2021academic year) Second semester  - その他6~9

  • How Do Medicines Work ? (2020academic year) Fourth semester  - 木1,木2

  • Immunology 1 (2020academic year) 1st semester  - 月3,月4

  • Immunology 1 (2020academic year) 1st semester  - 月3,月4

  • Immunology 2 (2020academic year) Second semester  - 月3,月4

  • Immunology 2 (2020academic year) Second semester  - 月3,月4

  • Immunology 3 (2020academic year) Third semester  - その他

  • Immunology 3 (2020academic year) Third semester  - その他

  • Immunology II (2020academic year) Third semester  - 月3,月4

  • Life science for drug discovery (2020academic year) Third semester  - 木5,木6

  • Regulation of Biological Reponses (2020academic year) special  - その他

  • Seminar on Regulation of Biological Reponses (2020academic year) special  - その他

  • Regulation of Biological Responses I (2020academic year) special  - その他

  • Regulation of Biological Responses II (2020academic year) special  - その他

  • Life Science 1 (2020academic year) special  - その他

  • Cell Biology 2 (2020academic year) Fourth semester  - その他

  • Cell Biology 2 (2020academic year) Fourth semester  - その他

  • Practice in Fundamental Pharmaceutical Sciences III (2020academic year) Second semester  - その他

  • Practice in Fundamental Pharmaceutical Sciences III (2020academic year) Second semester  - その他

▼display all